Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Pulmonology ; 30(2): 159-169, 2024.
Article in English | MEDLINE | ID: mdl-36717296

ABSTRACT

INTRODUCTION: The management of unresectable stage III non-small cell lung cancer (NSCLC) is clinically challenging and there is no current consensus on optimal strategies. Herein, a panel of Portuguese experts aims to present practical recommendations for the global management of unresectable stage III NSCLC patients. METHODS: A group of Portuguese lung cancer experts debated aspects related to the diagnosis, staging and treatment of unresectable stage III NSCLC in light of current evidence. Recent breakthroughs in immunotherapy as part of a standard therapeutic approach were also discussed. This review exposes the major conclusions obtained. RESULTS: Practical recommendations for the management of unresectable stage III NSCLC were proposed, aiming to improve the pathways of diagnosis and treatment in the Portuguese healthcare system. Clinical heterogeneity of patients with stage III NSCLC hinders the development of single standardised algorithm where all fit. CONCLUSIONS: A timely diagnosis and a proper staging contribute to the best management of each patient, optimizing treatment tolerance and effectiveness. The expert panel considered chemoradiotherapy as the preferable approach when surgery is not possible. Management of adverse events and immunotherapy as a consolidation therapy are also essential steps for a successful strategy.


Subject(s)
Carcinoma, Non-Small-Cell Lung , Lung Neoplasms , Humans , Carcinoma, Non-Small-Cell Lung/drug therapy , Lung Neoplasms/pathology , Portugal/epidemiology , Neoplasm Staging , Chemoradiotherapy
2.
Hepatogastroenterology ; 43(12): 1653-5, 1996.
Article in English | MEDLINE | ID: mdl-8975983

ABSTRACT

Tuberculous mesenteric lymphadenitis is a rare clinical entity and non-surgical diagnosis of this condition remains a challenge. A 38-year-old Indian woman presented with a six-week history of epigastric pain, low-grade fever and anorexia. Upper endoscopy showed a gastric ulcer of the posterior wall of the stomach. On CT scan there was a 8 cm abdominal mass involving the pancreatic body and tail and the endoscopic ultrasonography was also compatible with a cystic pancreatic tumor which had eroded into the stomach. An exploratory laparotomy was performed and the diagnosis of tuberculous mesenteric lymphadenitis was confirmed by bacteriological and histological examinations. Medical therapy was started after surgery. At 18 months she is asymptomatic and abdominal CT scan is normal. Tuberculosis of mesenteric lymph nodes usually raises serious diagnostic problems. A high grade of suspicion is necessary in order to perform a pre-operative diagnosis.


Subject(s)
Mesenteric Lymphadenitis/diagnosis , Pancreatic Neoplasms/diagnosis , Tuberculosis, Lymph Node/diagnosis , Adult , Female , Humans , Mesenteric Lymphadenitis/microbiology
3.
Virchows Arch ; 429(2-3): 101-8, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8917711

ABSTRACT

Alveolar adenoma of the lung is a poorly characterized, uncommon pulmonary lesion with proliferation of alveolar epithelium and septal mesenchyme. We describe the electron microscopy, immunohistochemistry and DNA flow cytometry in a case of alveolar adenoma in a 55-year-old woman. Alveolar adenoma appears to be a distinct benign neoplasm of the alveolar structures. Our findings further suggest that it is not a precursor of bronchioloalveolar carcinoma or other type II pneumocyte lesions of presumed malignant potential.


Subject(s)
Adenoma/pathology , Lung Neoplasms/pathology , Pulmonary Alveoli , Adenoma/metabolism , Female , Humans , Immunohistochemistry , Lung Neoplasms/metabolism , Microscopy, Electron , Middle Aged
4.
Teratog Carcinog Mutagen ; 16(5): 269-74, 1996.
Article in English | MEDLINE | ID: mdl-9122892

ABSTRACT

Epidemiological studies have led to the suggestion that a genetic basis may exist in the individual variation in predisposition to cancer. Interindividual differences in human toxicological response to carcinogenic exposure have been attributed to heritable polymorphisms in metabolism, namely glutathione S-transferases (GSTs) coding for enzymes that are known to be detoxifiers of carcinogens. Within the human GST mu class, there is a specific isozyme that is frequently lacking. To check whether or not this association exists in the Portuguese population with lung cancer, we used polymerase chain reaction (PCR)-based genotyping to examine GSTM1 polymorphism (nulled and non-nulled) in 84 individuals as a control healthy population and a group of 98 lung cancer patients. In this study we were able to find a frequency of the GSTM1 phenotype among our healthy control subjects consistent with earlier genotyping studies in other Caucasoid populations. For the group of individuals with lung cancer as a whole, or in subsets of histological subtypes, our data for the Portuguese population did not show a positive correlation between the null allele and this neoplasm. In contrast, we found a slight increase in the frequency of the wild-type allele in our lung cancer group.


Subject(s)
Carcinoma, Small Cell/epidemiology , Carcinoma, Squamous Cell/epidemiology , Glutathione Transferase/genetics , Isoenzymes/genetics , Lung Neoplasms/epidemiology , Polymorphism, Genetic , Carcinoma, Small Cell/enzymology , Carcinoma, Squamous Cell/enzymology , Disease Susceptibility , Electrophoresis, Polyacrylamide Gel , Genotype , Glutathione Transferase/metabolism , Humans , Isoenzymes/metabolism , Lung Neoplasms/enzymology , Polymerase Chain Reaction , Portugal/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...